Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: ESRRA ENSDARG00000069266

.

Description

estrogen-related receptor alpha [Source:ZFIN;Acc:ZDB-GENE-990415-68]

Location

Chromosome 21: 26,606,741-26,634,099 forward strand.

GRCz11:CM002905.2

About this gene

This gene has 3 transcripts (splice variants), 174 orthologues, 12 paralogues and is associated with 18 phenotypes.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSDART00000176008.2	ESRRA-203	1311	436aa	ENSDARP00000144183.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	Q6Q6F6	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical, APPRIS P1: Transcript(s) expected to code for the main functional isoform based solely on the core modules in the APPRIS. APPRIS is a system to annotate alternatively spliced transcripts based on a range of computational methods to identify the most functionally important transcript(s) of a gene. APPRIS P1,
ENSDART00000002767.5	ESRRA-201	1274	262aa	ENSDARP00000023136.4	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,
ENSDART00000142667.2	ESRRA-202	347	35aa	ENSDARP00000120639.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	-	3' truncation in transcript evidence prevents annotation of the end of the CDS.CDS 3' incomplete,

.

Summary

.

.